Mesenchymal Stem Cells for Osteoarthritis Treatment

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for OA

Recruiting Phase 1 Interventional Study
Osteoarthritis Spinal Arthritis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
92 (estimated)
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine · Other
Who this trial is looking for

This trial is looking for people with osteoarthritis to test a treatment involving stem cells derived from umbilical cords. Participants will receive these cells through an IV or directly in their joints.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with osteoarthritis.
  • I understand and am willing to sign a consent form.

You may not be able to join if

  • I have an active infection.
  • I have an active cancer.
  • I have chronic multisystem organ failure.
  • I am pregnant.
  • I have significant abnormalities from my lab tests before treatment.
  • I have a medical condition that affects my safety.
  • I abuse drugs.
  • I am a pre-menopausal woman not using contraception.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells delivered intravenously and intraarticularly for the treatment of Osteoarthritis.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of Osteoarthritis * Understanding and willingness to sign a written informed consent document Exclusion Criteria: * Active infection * Active cancer * Chronic multisystem organ failure * Pregnancy * Clinically significant Abnormalities on pre-treatment laboratory e…
Contacts

Chadwick Prodromos, MD

847-699-6810

care@thepsci.com

CONTACT